Objectives: 1. Discuss the difference between Europe and the US when it comes to the dermal filler market.
2. Review what is going on in the US, where things stand, and what we can hope for in the near to not too distant future.
Introduction: One major difference between Europe and the US when it comes to the dermal filler market, is that in Europe, there are many fillers and filler companies bringing a myriad of products to our colleagues, which allows them great variety when it comes to using them for wrinkle reduction or for volumization.
Results: This is in stark contrast to the US, where we have a limited number of dermal fillers, due to a more stringent approval process by the US FDA and by the higher costs of running the clinical trials needed to bring a filler to the market. Several new fillers have recently been or will be approved and several more are primed to begin US clinical trials looking for approval when those trials are complete.
Conclusion: This presentation will review what is going on in the US, where things stand, and what we can hope for in the near to not too distant future.
Декларация COI
Получили ли вы финансовую поддержку для поисков этой ТЕМЫ?
Да
Укажите, пожалуйста, лица (индивидуальное, предприятие, организация): Allergan, Galderma, Merz Aesthetic, Prollenium, Croma
Были ли вам предоставлены гонорары, выплаты или иная компенсация за вашу работу в этом исследовании?
Да
Укажите лица (физическое лицо, предприятие, ассоциация): Allergan, Galderma, Merz Aesthetic, Prollenium, Croma
Есть ли у Вас финансовые отношения с лицами, тесно конкурирующими с препаратами, изделиями или приборами, указанными в вашей презентации?
Нет
Вы владеете или подали заявку на какие-либо патенты по инструментам, лекарствам или материалам для вашего исследования?
Нет
Эта работа представлена благодаря поддержке: Allergan, Galderma, Merz Aesthetic, Prollenium, Croma